EcoDrugPlus

Tachykinin Receptor 2

Ensembl ID : ENSCHYG00000007301
Gene Symbol: TACR2
1 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSCHYG00000026435
Gene Symbol: TACR3
1 Cross references
258 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSCHYG00000020414
Gene Symbol: TERT
1 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSCHYG00000018526
Gene Symbol: TBXAS1
1 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSCHYG00000003508
Gene Symbol: TBXA2R
1 Cross references
194 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSCHYG00000017585
Gene Symbol: TYMS
1 Cross references
225 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSCHYG00000011439
Gene Symbol: THRB
1 Cross references
393 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSCHYG00000013156
Gene Symbol: TRHR
1 Cross references
269 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSCHYG00000003827
Gene Symbol: TLR2
1 Cross references
249 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSCHYG00000005655
Gene Symbol: TLR4
1 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSCHYG00000024000
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSCHYG00000023987
Gene Symbol: TLR8
1 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).